Target intelligence / Profile preview

Zinc finger and BTB domain-containing protein 24 (ZBTB24)

Target
ZBTB24
Molecular classification
Transcription factor, C2H2-type zinc finger protein, BTB/POZ-domain protein
01

Overview

Zinc finger and BTB domain-containing protein 24 (ZBTB24) is a member of the BTB-zinc finger family of transcription factors characterized by the presence of an N-terminal BTB (POZ) domain, a C-terminal domain with eight tandem C2H2-type zinc fingers, and an AT-hook motif[1][4][5]. The protein is highly conserved and plays a critical role in transcriptional activation, shown to positively regulate genes including CDCA7[1][4]. ZBTB24 mutations cause immunodeficiency, centromeric instability, and facial anomalies syndrome type 2 (ICF2), a rare autosomal recessive disorder marked by DNA hypomethylation and antibody deficiency[1][4][5]. Disease-associated missense mutations in ZBTB24 disrupt its DNA-binding or chromatin localization functions, impairing downstream gene activation[1][4]. While ZBTB24 is central in genomic stability and immune system function, there are currently no drug interactions or therapeutic targeting strategies reported[5].

Other names
KIAA0441ZNF450BIF1PATZ2ICF2POZ (BTB) and AT hook containing zinc finger 2zinc finger protein 450
02

Biological functions

Transcriptional regulationGene activation (notably of CDCA7)Chromatin and heterochromatin localizationRegulation of DNA methylation markersHematopoietic progenitor cell differentiation
03

Disease associations

Immunodeficiency, centromeric instability and facial anomalies syndrome type 2 (ICF2)Other disorders involving defective DNA methylation and antibody deficiency
04

Safety considerations

Loss-of-function mutations lead to autosomal recessive immunodeficiency syndromes characterized by DNA hypomethylation, antibody deficiency, and chromosomal instability

Beyond the preview

Go deeper on Zinc finger and BTB domain-containing protein 24 (ZBTB24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger and BTB domain-containing protein 24 (ZBTB24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call